Policy
-
Policy Matters
Taking Steps to Address Cancer Health DisparitiesCancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
-
The Coronavirus Impacts Cancer Clinical Trials
The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
by Anna Azvolinsky
-
Medicare Coverage for Next-Generation Sequencing Tests
Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
Opioid Overdoses in Cancer Patients and Survivors
The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
by Emma Yasinski
-
Secure Connections
Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.
by Kate Yandell
-
Forward Look
Targeted Treatments for TotsNew law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
Policy Matters
Keep Up Momentum for Medical Research FundingAdvocating for federal funds for medical research pays off when the effort is constant and compelling.
by Brandon L. Leonard, MA, and J. Tod Guidry, PhD
-
Cancer and Credit
The financial burden of a cancer diagnosis can lower a patient's credit score.
by Shelly Rosenfeld
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD